Based on a quality by design approach, a capillary electrophoresis method for the simultaneous determination of dextrodropropizine and the achiral precursor 1-phenylpiperazine in levodropropizine was developed. The analytical target profile was defined as a method allowing the simultaneous determination below the 0.5% level within a maximum analysis time of 20 min with an acceptable precision and accuracy. Based on scouting experiments, sulfated β-cyclodextrin in a 25 mM potassium phosphate buffer, pH 7.0, was selected. Subsequently, cyclodextrin concentration, propan-2-ol concentration, capillary temperature and applied voltage were identified as critical process parameters using a full factorial design followed by a central composite face-centered design for the final optimization of cyclodextrin concentration and temperature. The design space was obtained by Monte Carlo simulations. The final method comprised a 40/50.2 cm effective/total length, 75 µm inner diameter fused-silica-capillary, 25 mM potassium phosphate buffer, pH 7.0, containing 23.5 mg mL−1 sulfated β-cyclodextrin and 10% (v/v) propan-2-ol as background electrolyte, 16.3 °C capillary temperature and an applied voltage of 16.5 kV. The robustness was assessed using a Plackett–Burman design followed by method validation. Finally, the method was applied to the analysis levodropropizine reference substance of the European Pharmacopoeia and a liquid dosage form.
Capillary electrophoresis Chiral separation Levodropropizine Quality by design Enantiomeric purity
This is a preview of subscription content, log in to check access.
The gift of Quimbo® drops by Noweda (Essen, Germany) is gratefully acknowledged.
Complilance with Ethical Standards
Conflict of Interest
The authors have declared no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
Malandrino S, Melillo G, Bestetti A, Borsa M, Giuliani P, Tonon GC (1988) Antitussive properties of levodropropizine. Arzneim Forsch Drug Res 38:1141–1143Google Scholar
Giani R, Marinone E, Melillo G, Borsa M, Tonon GC (1988) Synthesis and pharmacological screening of new phenylpiperazinepropane derivatives and their enantiomers. Arzneim Forsch Drug Res 38:1139–1141Google Scholar
Monograph 1535 Levodropropizine (2016) European Pharmacopoeia, 9th edn. European Directorate for the Quality of Medicines, Strasbourg, FranceGoogle Scholar
Xun Y, Ao F, Qui J, Jiang L, Bai Z (2013) Enantiomeric separation of dropropizine on cellulose derivative-based chiral stationary phase. West China J Pharm Sci 5:495–497Google Scholar
Balaji N, Gabani BB, Todmal U, Sulochana SP, Saini NK, Chandra N, Mullangi R (2019) Enantioselective LC-ESI-MS/MS determination of dropropizine enantiomers in rat plasma and application to a pharmacokinetic study. Biomed Chromatogr 33:e4434. https://doi.org/10.1002/bmc.4434CrossRefPubMedGoogle Scholar
De Cock B, Mangelings D, Vander Heyden Y (2018) Interinstrumental transfer of a chiral capillary electrophoretic method: the use of robustness test information to overcome differences in detector and data-handling specifications. Chromatogrpahia 81:335–348. https://doi.org/10.1007/s10337-017-3429-5CrossRefGoogle Scholar